Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AIMT | BMY | AMGN | GILD | VRTX |
| Company | Aimmune Therap | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 34.56 | 48.21 | 264.63 | 66.25 | 394.72 |
| High | 34.56 | 49.05 | 269.38 | 66.83 | 396.98 |
| Low | 34.48 | 48.12 | 260.68 | 66.16 | 391.25 |
| Last | 34.49 | 48.93 | 268.93 | 66.76 | 394.28 |
| Change | -0.10 | +0.63 | +6.18 | +0.60 | +0.80 |
| % Change | -0.29% | +1.30% | +2.35% | +0.91% | +0.20% |
| Volume | 987,200 | 10,272,076 | 3,348,870 | 10,294,824 | 1,287,562 |
| 20-Day Average Volume | 1,628,530 | 11,117,103 | 2,170,926 | 6,168,434 | 904,823 |
| Previous Close | 34.59 | 48.30 | 262.75 | 66.16 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 34.37 | 50.85 | 272.57 | 69.90 | 405.51 |
| 20-Day Raw Stochastic | 70.59% | 18.95% | 30.16% | 10.41% | 10.50% |
| 20-Day Relative Strength | 83.15% | 41.08% | 44.12% | 31.14% | 37.68% |
| Weighted Alpha | -31.00 | -28.93 | +7.76 | -24.37 | +15.92 |
| Today's Opinion | 88% Buy | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Buy | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 56% Buy | 24% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 10/05/20 | +1.32% since 04/12/24 | +0.68% since 04/12/24 | -1.97% since 04/12/24 | -0.59% since 04/12/24 |
| Low | 34.42 on 10/07/20 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 34.59 on 10/09/20 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.85% since 09/11/20 | -5.57% since 03/19/24 | -0.97% since 03/19/24 | -9.10% since 03/19/24 | -5.06% since 03/19/24 |
| Low | 34.21 on 09/14/20 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 34.59 on 10/09/20 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +119.96% since 07/10/20 | -2.38% since 01/19/24 | -12.58% since 01/19/24 | -23.55% since 01/19/24 | -9.38% since 01/19/24 |
| Low | 11.82 on 08/28/20 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 34.59 on 10/09/20 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +115.29% since 04/09/20 | -13.39% since 10/19/23 | -4.10% since 10/19/23 | -14.93% since 10/19/23 | +8.06% since 10/19/23 |
| Low | 11.82 on 08/28/20 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 34.59 on 10/09/20 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,257,370 | 97,892,464 | 140,812,720 | 82,374,304 | 101,698,464 |
| Shares Outstanding, K | 65,450 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -248,500,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -69,240,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.76 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.06 on 07/30/20 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/04/20 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 29.25 |